September 9, 2023
Bio-Labs Launched Omezka (Omeprazole B.P) To Its Extensive Portfolio

Bio-Labs is thrilled to announce the launch of Omezka (Omeprazole B.P.) in our Pain and Gut Care Division. Omezka (Omeprazole B.P) is used to treat excess stomach acid in conditions such as non-cancerous stomach ulcers, gastroesophageal reflux disease (GERD), active duodenal ulcer, Zollinger-Ellison syndrome, and erosive esophagitis. Omeprazole works by blocking gastric acid production and is from a group of medicines called Proton Pump Inhibitors.

At Bio-Labs, we are dedicated to advancing healthcare through innovation. Omezka stands as a testament to our commitment to well-being!

article image